196 related articles for article (PubMed ID: 8690825)
1. Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo.
von Moltke LL; Greenblatt DJ; Duan SX; Harmatz JS; Wright CE; Shader RI
J Clin Psychopharmacol; 1996 Apr; 16(2):104-12. PubMed ID: 8690825
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin.
Desta Z; Soukhova N; Flockhart DA
J Clin Psychopharmacol; 2002 Apr; 22(2):162-8. PubMed ID: 11910261
[TBL] [Abstract][Full Text] [Related]
3. Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents.
von Moltke LL; Greenblatt DJ; Schmider J; Duan SX; Wright CE; Harmatz JS; Shader RI
J Clin Pharmacol; 1996 Sep; 36(9):783-91. PubMed ID: 8889898
[TBL] [Abstract][Full Text] [Related]
4. In vitro prediction of the terfenadine-ketoconazole pharmacokinetic interaction.
von Moltke LL; Greenblatt DJ; Duan SX; Harmatz JS; Shader RI
J Clin Pharmacol; 1994 Dec; 34(12):1222-7. PubMed ID: 7738219
[TBL] [Abstract][Full Text] [Related]
5. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers.
Raeissi SD; Hidalgo IJ; Segura-Aguilar J; Artursson P
Pharm Res; 1999 May; 16(5):625-32. PubMed ID: 10350002
[TBL] [Abstract][Full Text] [Related]
6. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.
von Moltke LL; Greenblatt DJ; Harmatz JS; Duan SX; Harrel LM; Cotreau-Bibbo MM; Pritchard GA; Wright CE; Shader RI
J Pharmacol Exp Ther; 1996 Feb; 276(2):370-9. PubMed ID: 8632299
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitors.
Zalma A; von Moltke LL; Granda BW; Harmatz JS; Shader RI; Greenblatt DJ
Biol Psychiatry; 2000 Apr; 47(7):655-61. PubMed ID: 10745059
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.
von Moltke LL; Greenblatt DJ; Schmider J; Harmatz JS; Shader RI
Clin Pharmacokinet; 1995; 29 Suppl 1():33-43; discussion 43-4. PubMed ID: 8846621
[TBL] [Abstract][Full Text] [Related]
9. Effect of dirithromycin on human CYP3A in vitro and on pharmacokinetics and pharmacodynamics of terfenadine in vivo.
Goldberg MJ; Ring B; DeSante K; Cerimele B; Hatcher B; Sides G; Wrighton S
J Clin Pharmacol; 1996 Dec; 36(12):1154-60. PubMed ID: 9013373
[TBL] [Abstract][Full Text] [Related]
10. The xenobiotic inhibitor profile of cytochrome P4502C8.
Ong CE; Coulter S; Birkett DJ; Bhasker CR; Miners JO
Br J Clin Pharmacol; 2000 Dec; 50(6):573-80. PubMed ID: 11136296
[TBL] [Abstract][Full Text] [Related]
11. Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo.
Preskorn SH; Alderman J; Greenblatt DJ; Horst WD
Psychopharmacol Bull; 1997; 33(4):659-65. PubMed ID: 9493476
[TBL] [Abstract][Full Text] [Related]
12. Comparison of CYP3A activities in a subclone of Caco-2 cells (TC7) and human intestine.
Raeissi SD; Guo Z; Dobson GL; Artursson P; Hidalgo IJ
Pharm Res; 1997 Aug; 14(8):1019-25. PubMed ID: 9279883
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
von Moltke LL; Greenblatt DJ; Cotreau-Bibbo MM; Duan SX; Harmatz JS; Shader RI
J Pharmacol Exp Ther; 1994 Mar; 268(3):1278-83. PubMed ID: 8138941
[TBL] [Abstract][Full Text] [Related]
14. The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite.
Fischer V; Rodríguez-Gascón A; Heitz F; Tynes R; Hauck C; Cohen D; Vickers AE
Drug Metab Dispos; 1998 Aug; 26(8):802-11. PubMed ID: 9698296
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants.
von Moltke LL; Greenblatt DJ; Court MH; Duan SX; Harmatz JS; Shader RI
J Clin Psychopharmacol; 1995 Apr; 15(2):125-31. PubMed ID: 7782485
[TBL] [Abstract][Full Text] [Related]
16. Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals.
Jurima-Romet M; Crawford K; Cyr T; Inaba T
Drug Metab Dispos; 1994; 22(6):849-57. PubMed ID: 7895601
[TBL] [Abstract][Full Text] [Related]
17. In vitro approaches to predicting drug interactions in vivo.
von Moltke LL; Greenblatt DJ; Schmider J; Wright CE; Harmatz JS; Shader RI
Biochem Pharmacol; 1998 Jan; 55(2):113-22. PubMed ID: 9448733
[TBL] [Abstract][Full Text] [Related]
18. Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.
Jurima-Romet M; Wright M; Neigh S
Br J Clin Pharmacol; 1998 Mar; 45(3):318-21. PubMed ID: 10896409
[TBL] [Abstract][Full Text] [Related]
19. Quantitative prediction of in vivo drug interactions between nevirapine and antifungal agents from in vitro data in rats.
Kishimoto W; Takano J; Senda C; Ishiguro N; Sakai K; Igarashi T
Biol Pharm Bull; 2000 Sep; 23(9):1027-32. PubMed ID: 10993198
[TBL] [Abstract][Full Text] [Related]
20. Lack of CYP3A inhibition effects of sertindole on terfenadine in healthy volunteers.
Wong SL; Cao G; Mack R; Granneman GR
Int J Clin Pharmacol Ther; 1998 Mar; 36(3):146-51. PubMed ID: 9562230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
